Bionano genomics announces pricing of $200 million underwritten public offering of common stock

San diego, jan. 20, 2021 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo), announced today the pricing of its previously announced underwritten public offering of 33,333,350 shares of its common stock at a price to the public of $6.00 per share. the gross proceeds to bionano from the offering, before deducting underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $200 million. in addition, bionano has granted the underwriters a 30-day option to purchase up to an additional 5,000,002 shares of common stock at the public offering price, less underwriting discounts and commissions, to cover over-allotments, if any. all of the shares in the offering are to be sold by bionano. the offering is expected to close on january 22, 2021, subject to customary closing conditions.
BNGO Ratings Summary
BNGO Quant Ranking